Insider Shareholders with Direct Ownership of Aytu Biopharma, Inc (AYTU)
This section provides a comprehensive overview of the insiders with direct ownership of Aytu Biopharma, Inc (AYTU). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
AYTU BIOPHARMA, INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
Director |
27,965,738 | 28,623,361 | 1,342,378 $2.62 Million | 13 |
Mar 29, 2021
Added 0.16%
|
|
Michael Macaluso
Director |
187,804 | 0 | 208,079 $405,754 | 1 |
Apr 16, 2021
Added 47.44%
|
|
Mark K Oki
Chief Financial Officer |
190,000 | 0 | 190,000 $370,500 | 2 |
Nov 18, 2022
Added 32.14%
|
|
Gary Cantrell
Director |
187,804 | 40,000 | 164,089 $319,973 | 2 |
Dec 21, 2022
Reduced 19.6%
|
|
Joshua R. Disbrow
Chief Executive Officer |
1,148,371 | 80,000 | 71,591 $139,602 | 5 |
Jun 14, 2023
Added 16.36%
|
|
Richard I Eisenstadt
Chief Financial Officer |
55,000 | 0 | 68,734 $134,031 | 1 |
Mar 31, 2021
Added 44.45%
|
|
Gerald W. Mc Laughlin
Director |
6,500 | 0 | 31,401 $61,231 | 1 |
Apr 08, 2021
Added 17.15%
|
|
Greg Pyszczymuka
Chief Commercial Officer |
114,083 | 0 | 23,185 $45,210 | 9 |
Sep 30, 2024
Added 0.89%
|
|
Beth Hecht
Director |
6,500 | 0 | 9,052 $17,651 | 1 |
Apr 08, 2021
Added 41.8%
|
| 189,304 | 40,000 | 8,940 $17,433 | 3 |
Aug 11, 2023
Added 14.37%
|
|
| 8,000 | 0 | 8,000 $15,600 | 2 |
Aug 16, 2023
Added 44.83%
|
|
| 189,304 | 187,804 | 2,262 $4,410 | 3 |
Aug 11, 2023
Added 39.87%
|
|
| 14,500 | 0 | 1,841 $3,589 | 3 |
Aug 11, 2023
Added 44.9%
|